Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin

Clinical Microbiology and Infection

Volumn 20, Issue 10, 2014, Pages O718-O720

  Ambrosioni, J ^a   Mamin, A ^a   Hadengue, A ^a   Bernimoulin, M ^a   Samii, K ^a   Landelle, C ^a   Negro, F ^a   Kaiser, L ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Chronic infection; Faecal shedding; Hepatitis E virus; Isolation; Viral load

Indexed keywords

AMINOTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RIBAVIRIN; VIRUS RNA; ALEMTUZUMAB; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION TEST; MIDDLE AGED; PRIORITY JOURNAL; SEROCONVERSION; VIRAL CLEARANCE; VIRUS LOAD; VIRUS SHEDDING; BLOOD; DIARRHEA; DRUG COMBINATION; DRUG EFFECTS; FECES; GENETICS; IMMUNOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY;

HEPATITIS E VIRUS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; DIARRHEA; DRUG THERAPY, COMBINATION; FECES; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84913611409     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12576     Document Type: Article

References (15)

1. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367 : 1237-1244.
2. Kamar N, Bendall R, Legrand-Abravanel F et al. Hepatitis E. Lancet 2012; 379: 2477-2488.
3. Kaba M, Richet H, Ravaux I et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011; 83: 1704-1716.
4. Halleux D, Kanaan N, Kabamba B, Thomas I, Hassoun Z. Hepatitis E virus: an underdiagnosed cause of chronic hepatitis in renal transplant recipients. Transpl Infect Dis 2012; 14: 99-102.
5. Halac U, Beland K, Lapierre P et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012; 160: 871-874.
6. Koenecke C, Pischke S, Heim A et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transpl Infect Dis 2012; 14: 103-106.
7. Jagjit Singh GK, Ijaz S, Rockwood N et al. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect 2013; 66 : 103-106.
8. Kamar N, Rostaing L, Abravanel F et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010; 139: 1612-1618.
9. Kamar N, Rostaing L, Abravanel F et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50: e30-e33.
10. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings Available online: http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf (last accessed 25 February 2014).
11. Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM, Izopet J. Genotype 3 diversity and quantification of hepatitis E virus RNA. J Clin Microbiol 2012; 50: 897-902.
12. Mallet V, Nicand E, Sultanik P et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153: 85-89.
13. Zhang HY, Chen DS, Wu YQ, He QG, Chen HC, Liu ZF. Both swine and human cells are capable to support the replication of swine hepatitis E virus type 4 in vitro. Virus Res 2011; 158: 289-293.
14. Rogee S, Talbot N, Caperna T, Bouquet J, Barnaud E, Pavio N. New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J Gen Virol 2013; 94(Pt 3): 549-558.
15. Williams TP, Kasorndorkbua C, Halbur PG et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J Clin Microbiol 2001; 39: 3040-3046.